Just as major sports organizations team with their preferred orthopedic specialists to optimize performance and prevent injury, world-class vocalists must trust their livelihood to highly- trained professionals. We are therefore proud to announce that the Center for the Performing Arts has chosen CENTA as its preferred group of ear, nose, and throat physicians. The Palladium, the home of the Center for the Performing Arts, has been touted as the most acoustically perfect music venue in the U.s, and opened in January, 2011. The Palladium has selected CENTA as its preferred medical group for its vocal performers, and renewed that relationship in 2011-2012. CENTA is the official sponsor of Vienna Boys Choir’s performances at the Palladium, and will celebrate that relationship by offering vocal health workshops for vocal students and professionals at this world class facility this year. Watch this space for additional information, and for a virtual tour of the Palladium, click here.
The most exciting and revolutionary developments in head and neck cancer surgery have been in da Vinci robotic surgery, and CENTA’s Drs. Tod Huntley and Ed Krowiak have established themselves as the region’s most experienced practitioners in this groundbreaking field. Their combined case volumes are among the largest in the country, and they have actively been involved in teaching and proctoring other surgeons in robotic surgical techniques. Dr. Huntley has been an invited guest speaker within this past year at the annual meetings of the two international organizations for robotic surgery, the Society for Robotic Surgery and the Clinical Robotic Surgery Association.
In 2011, Dr. Huntley lectured at the World Robotic Symposium and moderated its head and neck scientific session, and he will be on the faculty of the Miami Robotic Symposium in 2012. His article on robotic surgery for obstructive sleep apnea for Operative Techniques in Otolaryngology-Head and Neck Surgery will be published in late 2011. Dr. Huntley has proctored surgeons at their initial robotic surgical cases at a number of the most prominent US training programs in 2011 from Seattle to Miami, including Yale Medical Center and Brigham and Women’s Hospital (Harvard University).
The annual meeting of the AAO-HNS was held in September, 2011, in San Francisco, and played host to the largest gathering of ENt specialists in the world. CENTA’s Dr. Tod Huntley, a previous Honor Award recipient at that meeting, presented instructional courses this year on “da Vinci Transoral Robotic Surgery (TORS) for Obstructive Sleep Apnea” and on “Oral Appliance Therapy for Obstructive Sleep Apnea.” He co-authored a presentation of Hypoglossal Nerve Stimulator Implantation for Obstructive Sleep Apnea” at the meeting, and was attended the meeting of the Sleep Disorders Committee at the meeting, of which he is an active member.
NASA's space shuttle fleet began setting records with its first launch in 1981 and continued to set high marks of achievement and endurance through 30 years of missions since then. The Space Shuttle program has carried people into orbit repeatedly, launched, recovered and repaired satellites, conducted cutting-edge research and built the International Space Station. None of this could have been possible without NASA’s highly trained medical team, and CENTA’s Dr. Scott Phillips has been a senior flight surgeon for the shuttle program since 1999. He completed his role with the program when he served on the recovery team for the final shuttle landing in July, 2011 when Atlantis safely landed at the Kennedy Space Center in Florida.
Richard Huffaker, DO, began a one-year fellowship in head and neck cancer and reconstructive surgery at St. Vincent Hospital in July, 2011. Dr. Huffaker recently completed his residency in otolaryngology-head and neck surgery in Tulsa, Oklahoma, and will be working with CENTA’s distinguished team of of surgeons over the next twelve months. He will be learning the latest treatments for head and neck cancer, and will be trained in miicrovascular reconstructive surgery and robotic surgery techniques. He joins a long list of surgeons from the U.S., Europe, India, and Australia who have trained under CENTA physicians. He will also assist in the supervision and training of visiting otolaryngology residents from training programs around the country who rotate with CENTA at St. Vincent Hospital.
The FDA has approved further testing of the Apnex Hypoglossal Nerve Stimulator (HGNS) implant for obstructive sleep apnea in the summer of 2011. This innovative treatment involves the implantation of a pacemaker-like device that could prove to be an effective treatment option to many people who cannot tolerate other treatments for obstructive sleep apnea (OSA), such as nasal CPAP. Dr. Tod Huntley is a medical advisor for Apnex Medical, the developer of HGNS technology, participated in the feasibility trial of this technology, and is actively involved in future HGNS research. Dr. Huntley has been selected as a principle investigator for a multicenter international pivotal trial of this technique, and will begin enrolling subjects for the trial soon. Watch this space for more news of HGNS technology, and log on to www.apnexmedical.com for more details of the study.
DISCLAIMER: The information contained in this online website is only intended to provide broad consumer information about CENTA. The information should not be considered complete nor used in place of a visit, telephone call, consultation or advice of a physician or other healthcare provider. CENTA and its healthcare providers do not recommend the self-management of health problems. Information obtained by using this website is not exhaustive and does not cover all diseases, ailments, and physical conditions or their treatment. If you have any health-related questions, please call or see your physician or other healthcare provider promptly. You should not disregard medical advice or delay in seeking it because of something you have read on this website.